Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways
Pakistan Journal of Pharmaceutical Sciences · 12.11.2026
DOI: 10.36721/pjps/2026.40.16377.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Pharmaceutical Sciences, online erschienen am 12.11.2026. Verfasst von WanLin Wang. Die Arbeit nennt 55 Literaturangaben.
Abstract (Originalsprache)
Background
Chronic immune-mediated inflammation remains difficult to treat with single-target approaches. Terpenoids are known to modulate immune responses, but whether specific combinations can produce enhanced effects and through which mechanisms is not well understood.
Objectives
This study investigates whether a fixed-ratio combination (5:23:26) of (-)-Linalool, (-)-Borneol and β-Caryophyllene (Formula 1) exerts enhanced anti-inflammatory effects and explores the underlying molecular mechanisms.
Methods
Two complementary models were used: release of slow-reacting substance of anaphylaxis (SRS-A) in isolated guinea pig ileum and LPS-activated RAW264.7 macrophages. PGE2, LTB4, NO and iNOS levels were measured. Network pharmacology, followed by experimental validation, identified key targets and pathways. Cellular morphology, apoptosis and NF-κB p65 nuclear accumulation were assessed by Hoechst 33342/PI staining and fluorescent plasmid transfection.
Results
Formula 1 achieved 79.88% inhibition of SRS-A release, significantly surpassing every single component (P < 0.001) and the positive control quercetin. It also reduced PGE2, LTB4, NO and iNOS levels more effectively than any single compound. In LPS-stimulated macrophages, Formula 1 reduced cell deformation and apoptosis and markedly reduced p65 nuclear translocation. Mechanistically, it increased the Nrf2/HO-1 axis while down-regulating NF-κB and the arachidonic acid pathway. Notably, even when (-)-Linalool was reduced to one-tenth of its dose, Formula 1 maintained comparable efficacy.
Conclusions
The combination of (-)-Linalool, (-)-Borneol and β-Caryophyllene produces enhanced anti-inflammatory effects through coordinated regulation of multiple pathways, as supported by the Highest Single Agent (HSA) model. These findings provide a basis for developing multi-target therapies for immune-mediated inflammatory diseases
Zitieren
APA
Wang, W. (2026). Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps/2026.40.16377.1
Vancouver
Wang W. Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways. Pakistan Journal of Pharmaceutical Sciences. 2026. doi:10.36721/pjps/2026.40.16377.1
BibTeX
@article{Wang2026,
author = {Wang, WanLin},
title = {Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways},
journal = {Pakistan Journal of Pharmaceutical Sciences},
year = {2026},
doi = {10.36721/pjps/2026.40.16377.1}
}
EUVIMED